A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: A patient with Wilms' tumour is not a mutation carrier

British Journal of Cancer

Volumn 78, Issue 8, 1998, Pages 1081-1083

  Varley, J M ^a   McGown, G ^a   Thorncroft, M ^a   White, G R M ^a   Tricker, K J ^b   Kelsey, A M ^b   Birch, J M ^b   Evans, D G R ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Li Fraumeni syndrome; Splicing; TP53; Wilms' tumour

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; FAMILIAL CANCER; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; INTRON; MALE; NEPHROBLASTOMA; PRIORITY JOURNAL; RNA SPLICING; RNA TRANSCRIPTION;

EID: 0031666557     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.631     Document Type: Article

References (9)

1. Bardeesy N, Falkoff D, Petruzzi M-J, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T and Pelletier J (1994) Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genet 7: 91-97
2. Hartley AL, Birch JM, Tricker K, Wallace SA, Kelsey AM, Harris M and Morris Jones PH (1993) Wilms' tumor in the Li-Fraumeni cancer family syndrome. Cancer Genet Cytogenet 67: 133-135
3. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 24: 141-146
4. Lai M-Y, Chang H-C, Li H-P, Ku C-K, Chen P-J, Sheu J-C, Huang G-T, Lee P-H and Chen D-S (1993) Splicing mutations of the p53 gene in human hepatocellular carcinoma. Cancer Res 53: 1653-1656
5. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA and Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358-5362
6. Suzuki H, Takahashi T, Kuoishi T, Suyama M, Ariyoshi Y, Takahashi T and Ueda R (1992) p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 52: 734-736
7. Takahashi T, D'Amico D, Chiba I, Buchhagen DL and Minna JD (1990) Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J Clin Invest 86: 363-369
8. Varley JM, Chapman P, McGown G, Thorncroft M, White GRM, Greaves MJ, Scott D, Spreadborough A, Tricker KJ, Birch JM, Evans DGR, Reddel R, Camplejohn RS, Burn J and Boyle JM (1998) Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. Oncogene 16: 3291-3298
9. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DGR and Birch JM (1997) Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57: 3245-3252